{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["LDL", "PCSK9", "atherosclerosis", "cardiovascular disease", "natural products"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "PMID": "38899632", "DateRevised": {"Year": "2024", "Month": "07", "Day": "20"}, "Article": {"Language": ["eng"], "ELocationID": ["10.1002/ptr.8260"], "ArticleDate": [{"Year": "2024", "Month": "06", "Day": "20"}], "Journal": {"ISSN": "1099-1573", "JournalIssue": {"PubDate": {"Year": "2024", "Month": "Jun", "Day": "20"}}, "Title": "Phytotherapy research : PTR", "ISOAbbreviation": "Phytother Res"}, "ArticleTitle": "The role of natural products as PCSK9 modulators: A review.", "Abstract": {"AbstractText": ["A variety of mechanisms and drugs have been shown to attenuate cardiovascular disease (CVD) onset and/or progression. Recent researchers have identified a potential role of proprotein convertase subtilisin/kexin type 9 (PCSK9) in modulating lipid metabolism and reducing plasma low density lipoprotein (LDL) levels. PCSK9 is the central protein in the metabolism of LDL cholesterol (LDL-C) owing to its major function in LDL receptor (LDLR) degradation. Due to the close correlation of cardiovascular disease with lipid levels, many in vivo and in vitro investigations are currently underway studying the physiological role of PCSK9. Furthermore, many studies are actively investigating the mechanisms of various compounds that influence lipid associated-disorders and their associated cardiovascular diseases. PCSK9 inhibitors have been shown to have significant impact in the prevention of emerging cardiovascular diseases. Natural products can effectively be used as PCSK9 inhibitors to control lipid levels through various mechanisms. In this review, we evaluate the role of phytochemicals and natural products in the regulation of PCSK9, and their ability to prevent cardiovascular diseases. Moreover, we describe their mechanisms of action, which have not to date been delineated."], "CopyrightInformation": "\u00a9 2024 John Wiley & Sons Ltd."}, "AuthorList": [{"Identifier": ["0000-0003-3318-9076"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Toxicology & Pharmacology, Faculty of Pharmacy, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran."}, {"Identifier": [], "Affiliation": "GI Pharmacology Interest Group (GPIG), Universal Scientific Education and Research Network (USERN), Tehran, Iran."}], "LastName": "Khayatan", "ForeName": "Danial", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Medicine, Shahid Sadoughi University of Medical Sciences and Health Services, Yazd, Iran."}], "LastName": "Zare", "ForeName": "Kimia", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Toxicology & Pharmacology, Faculty of Pharmacy, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran."}, {"Identifier": [], "Affiliation": "GI Pharmacology Interest Group (GPIG), Universal Scientific Education and Research Network (USERN), Tehran, Iran."}], "LastName": "Khanahmadi", "ForeName": "Maryam", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants Research Center, Institute of Medicinal Plants, ACECR, Tehran, Iran."}, {"Identifier": [], "Affiliation": "Department of Toxicology and Pharmacology, School of Pharmacy, and Toxicology and Diseases Group, Pharmaceutical Sciences Research Center (PSRC), The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Momtaz", "ForeName": "Saeideh", "Initials": "S"}, {"Identifier": ["0000-0002-5762-3917"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Royal College of Surgeons in Ireland Bahrain, Adliya, Bahrain."}], "LastName": "Butler", "ForeName": "Alexandra E", "Initials": "AE"}, {"Identifier": ["0000-0001-9521-3153"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran."}, {"Identifier": [], "Affiliation": "Medical Toxicology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Jamialahmadi", "ForeName": "Tannaz", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Heart and Vascular Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates."}], "LastName": "Almahmeed", "ForeName": "Wael", "Initials": "W"}, {"Identifier": ["0000-0001-9961-9097"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Toxicology & Pharmacology, Faculty of Pharmacy, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran."}, {"Identifier": [], "Affiliation": "GI Pharmacology Interest Group (GPIG), Universal Scientific Education and Research Network (USERN), Tehran, Iran."}], "LastName": "Abdolghaffari", "ForeName": "Amir Hossein", "Initials": "AH"}, {"Identifier": ["0000-0002-8656-1444"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center for Global Health Research, Saveetha Medical College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India."}, {"Identifier": [], "Affiliation": "Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran."}, {"Identifier": [], "Affiliation": "Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Sahebkar", "ForeName": "Amirhossein", "Initials": "A"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Phytother Res", "NlmUniqueID": "8904486", "ISSNLinking": "0951-418X"}}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Adorni, M. P., Ferri, N., Marchian\u00f2, S., Trimarco, V., Rozza, F., Izzo, R., Bernini, F., & Zimetti, F. (2017). Effect of a novel nutraceutical combination on serum lipoprotein functional profile and circulating PCSK9. Therapeutics and Clinical Risk Management, 13, 1555\u20131562."}, {"Citation": "Aggrey, M. O., Li, H. H., Wang, W. Q., Wang, Y., & Xuan, L. J. (2019). Indole alkaloid from Nauclea latifolia promotes LDL uptake in HepG2 cells by inhibiting PCSK9. Phytomedicine, 55, 264\u2013268."}, {"Citation": "Ahmadi, A., Jamialahmadi, T., & Sahebkar, A. (2022). Polyphenols and atherosclerosis: A critical review of clinical effects on LDL oxidation. Pharmacological Research, 184, 106414."}, {"Citation": "Ahn, J., Chae, H. S., Pel, P., Kim, Y. M., Choi, Y. H., Kim, J., & Chin, Y. W. (2021). Dilignans with a chromanol motif discovered by molecular networking from the stem barks of Magnolia obovata and their proprotein convertase subtilisin/Kexin type 9 expression inhibitory activity. Biomolecules, 11(3), 463."}, {"Citation": "Altaf, R., Asmawi, M. Z., Dewa, A., Sadikun, A., & Umar, M. I. (2013). Phytochemistry and medicinal properties of Phaleria macrocarpa (Scheff.) Boerl extracts. Pharmacognosy Reviews, 7(13), 73\u201380."}, {"Citation": "Armenia, E., Widya, R., Rusdi, D., & Netty, M. (2006). Anti\u2010Atherosclerotic effect and liver toxicity of ethanolic extract of Phaleria macrocarpa (Scheff. Boerl) fruit on Japanese Quail. Asian symposium on medicinal plants, spices and other natural product XII (ASOMP), Padang, Indonesia."}, {"Citation": "Asgary, S., Kelishadi, R., Rafieian\u2010Kopaei, M., Najafi, S., Najafi, M., & Sahebkar, A. (2013). Investigation of the lipid\u2010modifying and antiinflammatory effects of cornus mas L. supplementation on dyslipidemic children and adolescents. Pediatric Cardiology, 34(7), 1729\u20131735."}, {"Citation": "Bagheri, H., Ghasemi, F., Barreto, G. E., Rafiee, R., Sathyapalan, T., & Sahebkar, A. (2020). Effects of curcumin on mitochondria in neurodegenerative diseases. BioFactors, 46(1), 5\u201320."}, {"Citation": "Bahrami, A., Parsamanesh, N., Atkin, S. L., Banach, M., & Sahebkar, A. (2018). Effect of statins on toll\u2010like receptors: A new insight to pleiotropic effects. Pharmacological Research, 135, 230\u2013238."}, {"Citation": "Banach, M., Reiner, Z., Cicero, A. F. G., Sabouret, P., Viigimaa, M., Sahebkar, A., Postadzhiyan, A., Gaita, D., Pella, D., & Penson, P. E. (2022). 2022: The year in cardiovascular disease\u2013The year of upfront lipid lowering combination therapy. Archives of Medical Science, 18(6), 1429\u20131434."}, {"Citation": "Bang, S., Chae, H. S., Lee, C., Choi, H. G., Ryu, J., Li, W., Lee, H., Jeong, G. S., Chin, Y. W., & Shim, S. H. (2017). New aromatic compounds from the fruiting body of Sparassis crispa (Wulf.) and their inhibitory activities on proprotein convertase subtilisin/Kexin type 9 mRNA expression. Journal of Agricultural and Food Chemistry, 65(30), 6152\u20136157."}, {"Citation": "Bentzon, J. F., Otsuka, F., Virmani, R., & Falk, E. (2014). Mechanisms of plaque formation and rupture. Circulation Research, 114(12), 1852\u20131866."}, {"Citation": "Bland, A. R., Payne, F. M., Ashton, J. C., Jamialahmadi, T., & Sahebkar, A. (2022). The cardioprotective actions of statins in targeting mitochondrial dysfunction associated with myocardial ischaemia\u2010reperfusion injury. Pharmacological Research, 175, 105986."}, {"Citation": "Cabral, R. S. C., Alves, C. C. F., Batista, H. R. F., Sousa, W. C., Abrah\u00e3o, I. S., Crotti, A. E. M., Santiago, M. B., Martins, C. H. G., & Miranda, M. L. D. (2020). Chemical composition of essential oils from different parts of protium heptaphyllum (Aubl.) Marchand and their in vitro antibacterial activity. Natural Product Research, 34(16), 2378\u20132383."}, {"Citation": "Cai, Y., Lu, D., Zou, Y., Zhou, C., Liu, H., Tu, C., Li, F., Liu, L., & Zhang, S. (2017). Curcumin protects against intestinal origin endotoxemia in rat liver cirrhosis by targeting PCSK9. Journal of Food Science, 82(3), 772\u2013780."}, {"Citation": "Cameron, J., Ranheim, T., Kulseth, M. A., Leren, T. P., & Berge, K. E. (2008). Berberine decreases PCSK9 expression in HepG2 cells. Atherosclerosis, 201(2), 266\u2013273."}, {"Citation": "Cao, R. Y., Zheng, Y., Zhang, Y., Jiang, L., Li, Q., Sun, W., Gu, W., Cao, W., Zhou, L., Zheng, H., & Yang, J. (2021). Berberine on the prevention and management of cardiometabolic disease: Clinical applications and mechanisms of action. The American Journal of Chinese Medicine, 49(7), 1645\u20131666."}, {"Citation": "Cao, S., Xu, P., Yan, J., Liu, H., Liu, L., Cheng, L., Qiu, F., & Kang, N. (2018). Berberrubine and its analog, hydroxypropyl\u2010berberrubine, regulate LDLR and PCSK9 expression via the ERK signal pathway to exert cholesterol\u2010lowering effects in human hepatoma HepG2 cells. Journal of Cellular Biochemistry, 120, 1340\u20131349."}, {"Citation": "Cao, Y. X., Liu, H. H., Li, S., & Li, J. J. (2019). A meta\u2010analysis of the effect of PCSK9\u2010monoclonal antibodies on circulating lipoprotein (a) levels. American Journal of Cardiovascular Drugs, 19(1), 87\u201397."}, {"Citation": "Cariou, B., Le May, C., & Costet, P. (2011). Clinical aspects of PCSK9. Atherosclerosis, 216(2), 258\u2013265."}, {"Citation": "Chang, H. Y., Wu, J. R., Gao, W. Y., Lin, H. R., Chen, P. Y., Chen, C. I., Wu, M. J., & Yen, J. H. (2019). The cholesterol\u2010modulating effect of methanol extract of pigeon pea (Cajanus cajan (L.) Millsp.) leaves on regulating LDLR and PCSK9 expression in HepG2 cells. Molecules, 24(3), 493."}, {"Citation": "Chaudhary, R., Garg, J., Shah, N., & Sumner, A. (2017). PCSK9 inhibitors: A new era of lipid lowering therapy. World Journal of Cardiology, 9(2), 76\u201391."}, {"Citation": "Chen, S. F., Chen, P. Y., Hsu, H. J., Wu, M. J., & Yen, J. H. (2017). Xanthohumol suppresses Mylip/Idol gene expression and modulates LDLR abundance and activity in HepG2 cells. Journal of Agricultural and Food Chemistry, 65(36), 7908\u20137918."}, {"Citation": "Cheng, Q. L., Li, H. L., Huang, Z. Q., Chen, Y. J., & Liu, T. S. (2015). 2\u03b2, 3\u03b2, 23\u2010trihydroxy\u2010urs\u201012\u2010ene\u201028\u2010olic acid (TUA) isolated from Actinidia chinensis Radix inhibits NCI\u2010H460 cell proliferation by decreasing NF\u2010\u03baB expression. Chemico\u2010Biological Interactions, 240, 1\u201311."}, {"Citation": "Choi, H. K., Hwang, J. T., Nam, T. G., Kim, S. H., Min, D. K., Park, S. W., & Chung, M. Y. (2017). Welsh onion extract inhibits PCSK9 expression contributing to the maintenance of the LDLR level under lipid depletion conditions of HepG2 cells. Food & Function, 8(12), 4582\u20134591."}, {"Citation": "Chong, S. C., Dollah, M. A., Chong, P. P., & Maha, A. (2011). Phaleria macrocarpa (Scheff.) Boerl fruit aqueous extract enhances LDL receptor and PCSK9 expression in vivo and in vitro. Journal of Ethnopharmacology, 137(1), 817\u2013827."}, {"Citation": "Cicero, A. F. G., Sahebkar, A., Fogacci, F., Bove, M., Giovannini, M., & Borghi, C. (2020). Effects of phytosomal curcumin on anthropometric parameters, insulin resistance, cortisolemia and non\u2010alcoholic fatty liver disease indices: A double\u2010blind, placebo\u2010controlled clinical trial. European Journal of Nutrition, 59(2), 477\u2013483."}, {"Citation": "De Castro\u2010Or\u00f3s, I., Sol\u00e0, R., Valls, R. M., Brea, A., Mozas, P., Puzo, J., & Pocov\u00ed, M. (2016). Genetic variants of LDLR and PCSK9 associated with variations in response to Antihypercholesterolemic effects of Armolipid plus with berberine. PLoS One, 11(3), e0150785."}, {"Citation": "Dentin, R., P\u00e9gorier, J. P., Benhamed, F., Foufelle, F., Ferr\u00e9, P., Fauveau, V., Magnuson, M. A., Girard, J., & Postic, C. (2004). Hepatic glucokinase is required for the synergistic action of ChREBP and SREBP\u20101c on glycolytic and lipogenic gene expression. The Journal of Biological Chemistry, 279(19), 20314\u201320326."}, {"Citation": "Dixon, D. L., Pamulapati, L. G., Bucheit, J. D., Sisson, E. M., Smith, S. R., Kim, C. J., Wohlford, G. F., & Pozen, J. (2019). Recent updates on the use of PCSK9 inhibitors in patients with atherosclerotic cardiovascular disease. Current Atherosclerosis Reports, 21(5), 16."}, {"Citation": "Dixon, D. L., Trankle, C., Buckley, L., Parod, E., Carbone, S., Van Tassell, B. W., & Abbate, A. (2016). A review of PCSK9 inhibition and its effects beyond LDL receptors. Journal of Clinical Lipidology, 10(5), 1073\u20131080."}, {"Citation": "Dong, B., Li, H., Singh, A. B., Cao, A., & Liu, J. (2015). Inhibition of PCSK9 transcription by berberine involves down\u2010regulation of hepatic HNF1\u03b1 protein expression through the ubiquitin\u2010proteasome degradation pathway. The Journal of Biological Chemistry, 290(7), 4047\u20134058."}, {"Citation": "Elseweidy, M. M., Sarhan Amin, R., Atteia, H. H., El\u2010Zeiky, R. R., & Al\u2010Gabri, N. A. (2018). New insight on a combination of policosanol and 10\u2010dehydrogingerdione phytochemicals as inhibitors for platelet activation biomarkers and atherogenicity risk in dyslipidemic rabbits: Role of CETP and PCSK9 inhibition. Applied Biochemistry and Biotechnology, 186(4), 805\u2013815."}, {"Citation": "Ference, B. A., Ginsberg, H. N., Graham, I., Ray, K. K., Packard, C. J., Bruckert, E., Hegele, R. A., Krauss, R. M., Raal, F. J., Schunkert, H., Watts, G. F., Bor\u00e9n, J., Fazio, S., Horton, J. D., Masana, L., Nicholls, S. J., Nordestgaard, B. G., van deSluis, B., Taskinen, M. R., \u2026 Catapano, A. L. (2017). Low\u2010density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. European Heart Journal, 38(32), 2459\u20132472."}, {"Citation": "Fern\u00e1ndez\u2010Friera, L., Pe\u00f1alvo, J. L., Fern\u00e1ndez\u2010Ortiz, A., Iba\u00f1ez, B., L\u00f3pez\u2010Melgar, B., Laclaustra, M., Oliva, B., Mocoroa, A., Mendiguren, J., Mart\u00ednez de Vega, V., Garc\u00eda, L., Molina, J., S\u00e1nchez\u2010Gonz\u00e1lez, J., Guzm\u00e1n, G., Alonso\u2010Farto, J. C., Guallar, E., Civeira, F., Sillesen, H., Pocock, S., \u2026 Fuster, V. (2015). Prevalence, vascular distribution, and multiterritorial extent of subclinical atherosclerosis in a middle\u2010aged cohort: The PESA (Progression of Early Subclinical Atherosclerosis) study. Circulation, 131(24), 2104\u20132113."}, {"Citation": "Fischedick, J. T., Hazekamp, A., Erkelens, T., Choi, Y. H., & Verpoorte, R. (2010). Metabolic fingerprinting of Cannabis sativa L., cannabinoids and terpenoids for chemotaxonomic and drug standardization purposes. Phytochemistry, 71(17\u201318), 2058\u20132073."}, {"Citation": "Fogacci, F., Banach, M., Mikhailidis, D. P., Bruckert, E., Toth, P. P., Watts, G. F., Reiner, \u017d., Mancini, J., Rizzo, M., Mitchenko, O., Pella, D., Fras, Z., Sahebkar, A., Vrablik, M., & Cicero, A. F. G. (2019). Safety of red yeast rice supplementation: A systematic review and meta\u2010analysis of randomized controlled trials. Pharmacological Research, 143, 1\u201316."}, {"Citation": "Formisano, E., Pasta, A., Cremonini, A. L., Favari, E., Ronca, A., Carbone, F., Semino, T., Di Pierro, F., Sukkar, S. G., & Pisciotta, L. (2020). Efficacy of nutraceutical combination of Monacolin K, berberine, and silymarin on lipid profile and PCSK9 plasma level in a cohort of hypercholesterolemic patients. Journal of Medicinal Food, 23(6), 658\u2013666."}, {"Citation": "Gallego\u2010Colon, E., Daum, A., & Yosefy, C. (2020). Statins and PCSK9 inhibitors: A new lipid\u2010lowering therapy. European Journal of Pharmacology, 878, 173114."}, {"Citation": "Ganjali, S., Riahi, M. M., Mahboobnia, K., Iranshahy, M., Banach, M., Jangjoo, A., Ashari, S., Tayarani\u2010Najaran, Z., & Sahebkar, A. (2023). An in vitro investigation of the effects of urolithins a and B on low\u2010density lipoprotein uptake and its regulatory genes. Archives of Medical Science, 19(6), 1832\u20131841."}, {"Citation": "Ghasemi, F., Bagheri, H., Barreto, G. E., Read, M. I., & Sahebkar, A. (2019). Effects of curcumin on microglial cells. Neurotoxicity Research, 36(1), 12\u201326."}, {"Citation": "Goldstein, J. L., & Brown, M. S. (2015). A century of cholesterol and coronaries: From plaques to genes to statins. Cell, 161(1), 161\u2013172."}, {"Citation": "Gorabi, A. M., Kiaie, N., Hajighasemi, S., Jamialahmadi, T., Majeed, M., & Sahebkar, A. (2019). The effect of curcumin on the differentiation of mesenchymal stem cells into mesodermal lineage. Molecules, 24(22), 4029."}, {"Citation": "Gorabi, A. M., Kiaie, N., Pirro, M., Bianconi, V., Jamialahmadi, T., & Sahebkar, A. (2021). Effects of statins on the biological features of mesenchymal stem cells and therapeutic implications. Heart Failure Reviews, 26(5), 1259\u20131272."}, {"Citation": "Grundy, S. M., Stone, N. J., Bailey, A. L., Beam, C., Birtcher, K. K., Blumenthal, R. S., Braun, L. T., deFerranti, S., Faiella\u2010Tommasino, J., Forman, D. E., Goldberg, R., Heidenreich, P. A., Hlatky, M. A., Jones, D. W., Lloyd\u2010Jones, D., Lopez\u2010Pajares, N., Ndumele, C. E., Orringer, C. E., Peralta, C. A., \u2026 Yeboah, J. (2019). 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: A report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. Journal of the American College of Cardiology, 73(24), e285\u2013e350."}, {"Citation": "Guo, T., Liu, Q., Hou, P., Li, F., Guo, S., Song, W., Zhang, H., Liu, X., Zhang, S., Zhang, J., Ho, C. T., & Bai, N. (2018). Stilbenoids and cannabinoids from the leaves of Cannabis sativa f. sativa with potential reverse cholesterol transport activity. Food & Function, 9(12), 6608\u20136617."}, {"Citation": "Hao, C. L., Lin, H. L., Ke, L. Y., Yen, H. W., & Shen, K. P. (2019). Pre\u2010germinated brown rice extract ameliorates high\u2010fat diet\u2010induced metabolic syndrome. Journal of Food Biochemistry, 43(3), e12769."}, {"Citation": "He, M., Hou, J., Wang, L., Zheng, M., Fang, T., Wang, X., & Xia, J. (2017). Actinidia chinensis Planch root extract inhibits cholesterol metabolism in hepatocellular carcinoma through upregulation of PCSK9. Oncotarget, 8(26), 42136\u201342148."}, {"Citation": "Hess, C. N., Low Wang, C. C., & Hiatt, W. R. (2018). PCSK9 inhibitors: Mechanisms of action, metabolic effects, and clinical outcomes. Annual Review of Medicine, 69, 133\u2013145."}, {"Citation": "Hirata, H., Yimin, S. S., Ozaki, M., Kobayashi, N., Shigyo, T., & Chiba, H. (2012). Xanthohumol prevents atherosclerosis by reducing arterial cholesterol content via CETP and apolipoprotein E in CETP\u2010transgenic mice. PLoS One, 7(11), e49415."}, {"Citation": "Iranshahi, M., Sahebkar, A., Hosseini, S. T., Takasaki, M., Konoshima, T., & Tokuda, H. (2010). Cancer chemopreventive activity of diversin from Ferula diversivittata in vitro and in vivo. Phytomedicine, 17(3\u20134), 269\u2013273."}, {"Citation": "Jamialahmadi, T., Panahi, Y., Safarpour, M. A., Ganjali, S., Chahabi, M., Reiner, Z., Solgi, S., Vahedian\u2010Azimi, A., Kianpour, P., Banach, M., & Sahebkar, A. (2019). Association of serum PCSK9 levels with antibiotic resistance and severity of disease in patients with bacterial infections admitted to intensive care units. Journal of Clinical Medicine, 8(10), 1742."}, {"Citation": "Jeong, H. S., Hong, S. J., Lee, T. B., Kwon, J. W., Jeong, J. T., Joo, H. J., Park, J. H., Ahn, C. M., Yu, C. W., & Lim, D. S. (2014). Effects of black raspberry on lipid profiles and vascular endothelial function in patients with metabolic syndrome. Phytotherapy Research, 28(10), 1492\u20131498."}, {"Citation": "Jia, Q., Cao, H., Shen, D., Li, S., Yan, L., Chen, C., Xing, S., & Dou, F. (2019). Quercetin protects against atherosclerosis by regulating the expression of PCSK9, CD36, PPAR\u03b3, LXR\u03b1 and ABCA1. International Journal of Molecular Medicine, 44(3), 893\u2013902."}, {"Citation": "Jia, Y. J., Xu, R. X., Sun, J., Tang, Y., & Li, J. J. (2014). Enhanced circulating PCSK9 concentration by berberine through SREBP\u20102 pathway in high fat diet\u2010fed rats. Journal of Translational Medicine, 12, 103."}, {"Citation": "Jia, Y. J., Zhang, Y., Liu, J., Guo, Y. L., Xu, R. X., & Li, J. J. (2016). Short\u2010 and long\u2010term effects of xuezhikang, an extract of cholestin, on serum proprotein convertase subtilisin/kexin type 9 levels. Chinese Journal of Integrative Medicine, 22(2), 96\u2013100."}, {"Citation": "Kandelouei, T., Abbasifard, M., Imani, D., Aslani, S., Razi, B., Fasihi, M., Shafiekhani, S., Mohammadi, K., Jamialahmadi, T., Reiner, \u017d., & Sahebkar, A. (2022). Effect of statins on serum level of hs\u2010CRP and CRP in patients with cardiovascular diseases: A systematic review and meta\u2010analysis of randomized controlled trials. Mediators of Inflammation, 2022, 1\u201320."}, {"Citation": "Keihanian, F., Saeidinia, A., Bagheri, R. K., Johnston, T. P., & Sahebkar, A. (2018). Curcumin, hemostasis, thrombosis, and coagulation. Journal of Cellular Physiology, 233(6), 4497\u20134511."}, {"Citation": "Khayatan, D., Razavi, S. M., Arab, Z. N., Niknejad, A. H., Nouri, K., Momtaz, S., Gumpricht, E., Jamialahmadi, T., Abdolghaffari, A. H., Barreto, G. E., & Sahebkar, A. (2022). Protective effects of curcumin against traumatic brain injury. Biomedicine and Pharmacotherapy, 154, 113621."}, {"Citation": "Krishnamurthi, R. V., Ikeda, T., & Feigin, V. L. (2020). Global, regional and country\u2010specific burden of Ischaemic stroke, intracerebral Haemorrhage and subarachnoid Haemorrhage: A systematic analysis of the global burden of disease study 2017. Neuroepidemiology, 54(2), 171\u2013179."}, {"Citation": "Kysenius, K., & Huttunen, H. J. (2016). Stress\u2010induced upregulation of VLDL receptor alters Wnt\u2010signaling in neurons. Experimental Cell Research, 340(2), 238\u2013247."}, {"Citation": "Lammi, C., Bellumori, M., Cecchi, L., Bartolomei, M., Bollati, C., Clodoveo, M. L., Corbo, F., Arnoldi, A., & Mulinacci, N. (2020). Extra virgin olive oil phenol extracts exert Hypocholesterolemic effects through the modulation of the LDLR pathway: In vitro and cellular mechanism of action elucidation. Nutrients, 12(6), 1723."}, {"Citation": "Lammi, C., Mulinacci, N., Cecchi, L., Bellumori, M., Bollati, C., Bartolomei, M., Franchini, C., Clodoveo, M. L., Corbo, F., & Arnoldi, A. (2020). Virgin Olive oil extracts reduce oxidative stress and modulate cholesterol metabolism: Comparison between oils obtained with traditional and innovative processes. Antioxidants (Basel), 9(9), 798."}, {"Citation": "Latimer, J., Batty, J. A., Neely, R. D., & Kunadian, V. (2016). PCSK9 inhibitors in the prevention of cardiovascular disease. Journal of Thrombosis and Thrombolysis, 42(3), 405\u2013419."}, {"Citation": "Li, H., Dong, B., Park, S. W., Lee, H. S., Chen, W., & Liu, J. (2009). Hepatocyte nuclear factor 1alpha plays a critical role in PCSK9 gene transcription and regulation by the natural hypocholesterolemic compound berberine. The Journal of Biological Chemistry, 284(42), 28885\u201328895."}, {"Citation": "Li, L., Shen, C., Huang, Y. X., Li, Y. N., Liu, X. F., Liu, X. M., & Liu, J. H. (2018). A new strategy for rapidly screening natural inhibitors targeting the PCSK9/LDLR interaction in vitro. Molecules, 23(9), 2397."}, {"Citation": "Li, S., Cao, H., Shen, D., Jia, Q., Chen, C., & Xing, S. L. (2018). Quercetin protects against ox\u2010LDL\u2010induced injury via regulation of ABCAl, LXR\u2010\u03b1 and PCSK9 in RAW264.7 macrophages. Molecular Medicine Reports, 18(1), 799\u2013806."}, {"Citation": "Li, S. S., Cao, H., Shen, D. Z., Chen, C., Xing, S. L., Dou, F. F., & Jia, Q. L. (2020). Effect of quercetin on atherosclerosis based on expressions of ABCA1, LXR\u2010\u03b1 and PCSK9 in ApoE(\u2212/\u2212) mice. Chinese Journal of Integrative Medicine, 26(2), 114\u2013121."}, {"Citation": "Lin, X. L., Xiao, L. L., Tang, Z. H., Jiang, Z. S., & Liu, M. H. (2018). Role of PCSK9 in lipid metabolism and atherosclerosis. Biomedicine & Pharmacotherapy, 104, 36\u201344."}, {"Citation": "Liu, D.\u2010l., Xu, L.\u2010J., Dong, H., Chen, G., Huang, Z.\u2010Y., Zou, X., Wang, K.\u2010F., Luo, Y.\u2010H., & Lu, F.\u2010E. (2015). Inhibition of proprotein convertase subtilisin/kexin type 9: A novel mechanism of berberine and 8\u2010hydroxy dihydroberberine against hyperlipidemia. Chinese Journal of Integrative Medicine, 21(2), 132\u2013138."}, {"Citation": "Liu, H. H., Li, S., Cao, Y. X., Guo, Y. L., Zhu, C. G., Wu, N. Q., & Li, J. J. (2021). Association of triglyceride\u2010rich lipoprotein\u2010cholesterol with recurrent cardiovascular events in statin\u2010treated patients according to different inflammatory status. Atherosclerosis, 330, 29\u201335."}, {"Citation": "Losito, I., Abbattista, R., De Ceglie, C., Castellaneta, A., Calvano, C. D., & Cataldi, T. R. I. (2021). Bioactive Secoiridoids in Italian extra\u2010virgin Olive oils: Impact of Olive Plant cultivars, cultivation regions and processing. Molecules, 26(3), 743."}, {"Citation": "Lu, Z., Kou, W., Du, B., Wu, Y., Zhao, S., Brusco, O. A., Morgan, J. M., Capuzzi, D. M., & Li, S. (2008). Effect of Xuezhikang, an extract from red yeast Chinese rice, on coronary events in a Chinese population with previous myocardial infarction. The American Journal of Cardiology, 101(12), 1689\u20131693."}, {"Citation": "Luo, Q. F., Sun, L., Si, J. Y., & Chen, D. H. (2008). Hypocholesterolemic effect of stilbenes containing extract\u2010fraction from Cajanus cajan L. on diet\u2010induced hypercholesterolemia in mice. Phytomedicine, 15(11), 932\u2013939."}, {"Citation": "Lupo, M. G., Macchi, C., Marchian\u00f2, S., Cristofani, R., Greco, M. F., Dall'Acqua, S., Chen, H., Sirtori, C. R., Corsini, A., Ruscica, M., & Ferri, N. (2019). Differential effects of red yeast rice, Berberis aristata and Morus alba extracts on PCSK9 and LDL uptake. Nutrition, Metabolism, and Cardiovascular Diseases, 29(11), 1245\u20131253."}, {"Citation": "Mahboobnia, K., Pirro, M., Marini, E., Grignani, F., Bezsonov, E. E., Jamialahmadi, T., & Sahebkar, A. (2021). PCSK9 and cancer: Rethinking the link. Biomedicine and Pharmacotherapy., 140, 111758."}, {"Citation": "Majeed, M. L., Ghafil, F. A., Fatima, G., Hadi, N. R., & Mahdi, H. F. (2021). Anti\u2010atherosclerotic and anti\u2010inflammatory effects of curcumin on hypercholesterolemic male rabbits. Indian Journal of Clinical Biochemistry, 36(1), 74\u201380."}, {"Citation": "Mannino, G., Iovino, P., Lauria, A., Genova, T., Asteggiano, A., Notarbartolo, M., Porcu, A., Serio, G., Chinig\u00f2, G., Occhipinti, A., Capuzzo, A., Medana, C., Munaron, L., & Gentile, C. (2021). Bioactive triterpenes of protium heptaphyllum gum resin extract display cholesterol\u2010lowering potential. International Journal of Molecular Sciences, 22(5), 2664."}, {"Citation": "Marjaneh, R. M., Rahmani, F., Hassanian, S. M., Rezaei, N., Hashemzehi, M., Bahrami, A., Ariakia, F., Fiuji, H., Sahebkar, A., Avan, A., & Khazaei, M. (2018). Phytosomal curcumin inhibits tumor growth in colitis\u2010associated colorectal cancer. Journal of Cellular Physiology, 233(10), 6785\u20136798."}, {"Citation": "Miranda, C. L., Elias, V. D., Hay, J. J., Choi, J., Reed, R. L., & Stevens, J. F. (2016). Xanthohumol improves dysfunctional glucose and lipid metabolism in diet\u2010induced obese C57BL/6J mice. Archives of Biochemistry and Biophysics, 599, 22\u201330."}, {"Citation": "Mohajeri, M., & Sahebkar, A. (2018). Protective effects of curcumin against doxorubicin\u2010induced toxicity and resistance: A review. Critical Reviews in Oncology/Hematology, 122, 30\u201351."}, {"Citation": "Mohammadi, A., Blesso, C. N., Barreto, G. E., Banach, M., Majeed, M., & Sahebkar, A. (2019). Macrophage plasticity, polarization and function in response to curcumin, a diet\u2010derived polyphenol, as an immunomodulatory agent. Journal of Nutritional Biochemistry, 66, 1\u201316."}, {"Citation": "Mokhtari\u2010Zaer, A., Marefati, N., Atkin, S. L., Butler, A. E., & Sahebkar, A. (2018). The protective role of curcumin in myocardial ischemia\u2013reperfusion injury. Journal of Cellular Physiology, 234(1), 214\u2013222."}, {"Citation": "Mollazadeh, H., Tavana, E., Fanni, G., Bo, S., Banach, M., Pirro, M., vonHaehling, S., Jamialahmadi, T., & Sahebkar, A. (2021). Effects of statins on mitochondrial pathways. Journal of Cachexia, Sarcopenia and Muscle, 12(2), 237\u2013251."}, {"Citation": "Momtazi, A. A., Banach, M., Pirro, M., Katsiki, N., & Sahebkar, A. (2017). Regulation of PCSK9 by nutraceuticals. Pharmacological Research, 120, 157\u2013169."}, {"Citation": "Momtazi, A. A., Banach, M., Pirro, M., Stein, E. A., & Sahebkar, A. (2017). PCSK9 and diabetes: Is there a link? Drug Discovery Today, 22(6), 883\u2013895."}, {"Citation": "Momtazi\u2010Borojeni, A. A., Banach, M., Ruscica, M., & Sahebkar, A. (2022). The role of PCSK9 in NAFLD/NASH and therapeutic implications of PCSK9 inhibition. Expert Review of Clinical Pharmacology, 15(10), 1199\u20131208."}, {"Citation": "Momtazi\u2010Borojeni, A. A., Sabouri\u2010Rad, S., Gotto, A. M., Pirro, M., Banach, M., Awan, Z., Barreto, G. E., & Sahebkar, A. (2019). PCSK9 and inflammation: A review of experimental and clinical evidence. European Heart Journal Cardiovascular Pharmacotherapy, 5(4), 237\u2013245."}, {"Citation": "Nakajima, K., Nakano, T., Tokita, Y., Nagamine, T., Inazu, A., Kobayashi, J., Mabuchi, H., Stanhope, K. L., Havel, P. J., Okazaki, M., Ai, M., & Tanaka, A. (2011). Postprandial lipoprotein metabolism: VLDL vs chylomicrons. Clinica Chimica Acta, 412(15\u201316), 1306\u20131318."}, {"Citation": "Nhoek, P., Chae, H. S., Masagalli, J. N., Mailar, K., Pel, P., Kim, Y. M., Choi, W. J., & Chin, Y. W. (2018). Discovery of flavonoids from Scutellaria baicalensis with inhibitory activity against PCSK 9 expression: Isolation, synthesis and their biological evaluation. Molecules, 23(2), 504."}, {"Citation": "Nicholls, S. J. (2019). The new face of hyperlipidemia and the role of PCSK9 inhibitors. Current Cardiology Reports, 21(4), 18."}, {"Citation": "Ochin, C. C., & Garelnabi, M. (2018). Berberine encapsulated PLGA\u2010PEG nanoparticles modulate PCSK\u20109 in HepG2 cells. Cardiovascular & Hematological Disorders Drug Targets, 18(1), 61\u201370."}, {"Citation": "O'Donoghue, M. L., Fazio, S., Giugliano, R. P., Stroes, E. S. G., Kanevsky, E., Gouni\u2010Berthold, I., Im, K., Lira Pineda, A., Wasserman, S. M., \u010ce\u0161ka, R., Ezhov, M. V., Jukema, J. W., Jensen, H. K., Tokg\u00f6zo\u011flu, S. L., Mach, F., Huber, K., Sever, P. S., Keech, A. C., Pedersen, T. R., & Sabatine, M. S. (2019). Lipoprotein(a), PCSK9 inhibition, and cardiovascular risk. Circulation, 139(12), 1483\u20131492."}, {"Citation": "Ooi, T. C., Krysa, J. A., Chaker, S., Abujrad, H., Mayne, J., Henry, K., Cousins, M., Raymond, A., Favreau, C., Taljaard, M., Chr\u00e9tien, M., Mbikay, M., Proctor, S. D., & Vine, D. F. (2017). The effect of PCSK9 loss\u2010of\u2010function variants on the postprandial lipid and ApoB\u2010lipoprotein response. The Journal of Clinical Endocrinology and Metabolism, 102(9), 3452\u20133460."}, {"Citation": "Panahi, Y., Fazlolahzadeh, O., Atkin, S. L., Majeed, M., Butler, A. E., Johnston, T. P., & Sahebkar, A. (2019). Evidence of curcumin and curcumin analogue effects in skin diseases: A narrative review. Journal of Cellular Physiology, 234(2), 1165\u20131178."}, {"Citation": "Panahi, Y., Khalili, N., Sahebi, E., Namazi, S., Reiner, \u017d., Majeed, M., & Sahbekar, A. (2017). Curcuminoids modify lipid profile in type 2 diabetes mellitus: A randomized controlled trial. Complementary Therapies in Medicine, 33, 1\u20135."}, {"Citation": "Parra\u2010Virto, A., Torres do Rego, A., Demelo\u2010Rodr\u00edguez, P., Mill\u00e1n N\u00fa\u00f1ez\u2010Cort\u00e9s, J., & \u00c1lvarez\u2010Sala, L. A. (2018). Usefulness of compounds with monacolin K in a case of statins intolerance. Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis, 30(6), 268\u2013270."}, {"Citation": "Pirro, M., Francisci, D., Bianconi, V., Schiaroli, E., Mannarino, M. R., Barsotti, F., Spinozzi, A., Bagaglia, F., Sahebkar, A., & Baldelli, F. (2019). NUtraceutical TReatment for hYpercholesterolemia in HIV\u2010infected patients: The NU\u2010TRY(HIV) randomized cross\u2010over trial. Atherosclerosis, 280, 51\u201357."}, {"Citation": "Pirro, M., Mannarino, M. R., Bianconi, V., Simental\u2010Mend\u00eda, L. E., Bagaglia, F., Mannarino, E., & Sahebkar, A. (2016). The effects of a nutraceutical combination on plasma lipids and glucose: A systematic review and meta\u2010analysis of randomized controlled trials. Pharmacological Research, 110, 76\u201388."}, {"Citation": "Pirro, M., Mannarino, M. R., Ministrini, S., Fallarino, F., Lupattelli, G., Bianconi, V., Bagaglia, F., & Mannarino, E. (2016). Effects of a nutraceutical combination on lipids, inflammation and endothelial integrity in patients with subclinical inflammation: A randomized clinical trial. Scientific Reports, 6, 23587."}, {"Citation": "Pisciotta, L., Bellocchio, A., & Bertolini, S. (2012). Nutraceutical pill containing berberine versus ezetimibe on plasma lipid pattern in hypercholesterolemic subjects and its additive effect in patients with familial hypercholesterolemia on stable cholesterol\u2010lowering treatment. Lipids in Health and Disease, 11, 123."}, {"Citation": "Reyes\u2010Soffer, G., Pavlyha, M., Ngai, C., Thomas, T., Holleran, S., Ramakrishnan, R., Karmally, W., Nandakumar, R., Fontanez, N., Obunike, J., Marcovina, S. M., Lichtenstein, A. H., Matthan, N. R., Matta, J., Maroccia, M., Becue, F., Poitiers, F., Swanson, B., Cowan, L., \u2026 Ginsberg, H. N. (2017). Effects of PCSK9 inhibition with alirocumab on lipoprotein metabolism in healthy humans. Circulation, 135(4), 352\u2013362."}, {"Citation": "Rezaee, R., Momtazi, A. A., Monemi, A., & Sahebkar, A. (2017). Curcumin: A potentially powerful tool to reverse cisplatin\u2010induced toxicity. Pharmacological Research, 117, 218\u2013227."}, {"Citation": "Ruscica, M., Pavanello, C., Gandini, S., Macchi, C., Botta, M., Dall'Orto, D., Del Puppo, M., Bertolotti, M., Bosisio, R., Mombelli, G., Sirtori, C. R., Calabresi, L., & Magni, P. (2019). Nutraceutical approach for the management of cardiovascular risk\u2010a combination containing the probiotic bifidobacterium longum BB536 and red yeast rice extract: Results from a randomized, double\u2010blind, placebo\u2010controlled study. Nutrition Journal, 18(1), 13."}, {"Citation": "Sabatine, M. S., Giugliano, R. P., Keech, A. C., Honarpour, N., Wiviott, S. D., Murphy, S. A., Kuder, J. F., Wang, H., Liu, T., Wasserman, S. M., Sever, P. S., & Pedersen, T. R. (2017). Evolocumab and clinical outcomes in patients with cardiovascular disease. The New England Journal of Medicine, 376(18), 1713\u20131722."}, {"Citation": "Sahebkar, A. (2014). Curcuminoids for the management of hypertriglyceridaemia. Nature Reviews Cardiology, 11(2), 123."}, {"Citation": "Sahebkar, A., Chew, G. T., & Watts, G. F. (2014). Recent advances in pharmacotherapy for hypertriglyceridemia. Progress in Lipid Research, 56(1), 47\u201366."}, {"Citation": "Sahebkar, A., Serban, M. C., Gluba\u2010Brz\u00f3zka, A., Mikhailidis, D. P., Cicero, A. F., Rysz, J., & Banach, M. (2016). Lipid\u2010modifying effects of nutraceuticals: An evidence\u2010based approach. Nutrition, 32(11\u201312), 1179\u20131192."}, {"Citation": "Sahebkar, A., & Watts, G. F. (2013a). New LDL\u2010cholesterol lowering therapies: Pharmacology, clinical trials, and relevance to acute coronary syndromes. Clinical Therapeutics, 35(8), 1082\u20131098."}, {"Citation": "Sahebkar, A., & Watts, G. F. (2013b). New therapies targeting apoB metabolism for high\u2010risk patients with inherited dyslipidaemias: What can the clinician expect? Cardiovascular Drugs and Therapy, 27(6), 559\u2013567."}, {"Citation": "Sarrica, A., Kirika, N., Romeo, M., Salmona, M., & Diomede, L. (2018). Safety and toxicology of magnolol and honokiol. Planta Medica, 84(16), 1151\u20131164."}, {"Citation": "Schluter, K. D., Wolf, A., & Schreckenberg, R. (2020). Coming Back to physiology: Extra hepatic functions of proprotein convertase subtilisin/Kexin type 9. Frontiers in Physiology, 11, 598649."}, {"Citation": "Schwartz, G. G., Steg, P. G., Szarek, M., Bhatt, D. L., Bittner, V. A., Diaz, R., Edelberg, J. M., Goodman, S. G., Hanotin, C., Harrington, R. A., Jukema, J. W., Lecorps, G., Mahaffey, K. W., Moryusef, A., Pordy, R., Quintero, K., Roe, M. T., Sasiela, W. J., Tamby, J. F., \u2026 Zeiher, A. M. (2018). Alirocumab and cardiovascular outcomes after acute coronary syndrome. The New England Journal of Medicine, 379(22), 2097\u20132107."}, {"Citation": "Serban, C., Sahebkar, A., Ursoniu, S., Mikhailidis, D. P., Rizzo, M., Lip, G. Y. H., Kees Hovingh, G., Kastelein, J. J. P., Kalinowski, L., Rysz, J., & Banach, M. (2015). A systematic review and meta\u2010analysis of the effect of statins on plasma asymmetric dimethylarginine concentrations. Scientific Reports, 5, 5."}, {"Citation": "Soltani, S., Boozari, M., Cicero, A. F. G., Jamialahmadi, T., & Sahebkar, A. (2021). Effects of phytochemicals on macrophage cholesterol efflux capacity: Impact on atherosclerosis. Phytotherapy Research, 35(6), 2854\u20132878."}, {"Citation": "Song, K. H., Kim, Y. H., Im, A. R., & Kim, Y. H. (2018). Black raspberry extract enhances LDL uptake in HepG2 cells by suppressing PCSK9 expression to upregulate LDLR expression. Journal of Medicinal Food, 21(6), 560\u2013567."}, {"Citation": "Spigoni, V., Aldigeri, R., Antonini, M., Micheli, M. M., Fantuzzi, F., Fratter, A., Pellizzato, M., Derlindati, E., Zavaroni, I., Bonadonna, R. C., & Dei, C. A. (2017). Effects of a new nutraceutical formulation (berberine, red yeast Rice and chitosan) on non\u2010HDL cholesterol levels in individuals with dyslipidemia: Results from a randomized, double blind, placebo\u2010controlled study. International Journal of Molecular Sciences, 18(7), 1498."}, {"Citation": "Steffens, D., Bramlage, P., Scheeff, C., Kasner, M., Hassanein, A., Friebel, J., & Rauch\u2010Kr\u00f6hnert, U. (2020). PCSK9 inhibitors and cardiovascular outcomes. Expert Opinion on Biological Therapy, 20(1), 35\u201347."}, {"Citation": "Stoekenbroek, R. M., Lambert, G., Cariou, B., & Hovingh, G. K. (2018). Inhibiting PCSK9 \u2010 biology beyond LDL control. Nature Reviews Endocrinology, 15(1), 52\u201362."}, {"Citation": "Stone, N. J., Robinson, J. G., Lichtenstein, A. H., Bairey Merz, C. N., Blum, C. B., Eckel, R. H., Goldberg, A. C., Gordon, D., Levy, D., Lloyd\u2010Jones, D. M., McBride, P., Schwartz, J. S., Shero, S. T., Smith, S. C., Jr., Watson, K., & Wilson, P. W. (2014). ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: A report of the American College of Cardiology/American Heart Association task force on practice guidelines. Journal of the American College of Cardiology, 63(25 Pt B, 2889\u20132934."}, {"Citation": "Tai, M. H., Chen, P. K., Chen, P. Y., Wu, M. J., Ho, C. T., & Yen, J. H. (2014). Curcumin enhances cell\u2010surface LDLR level and promotes LDL uptake through downregulation of PCSK9 gene expression in HepG2 cells. Molecular Nutrition & Food Research, 58(11), 2133\u20132145."}, {"Citation": "Topchiy, E., Cirstea, M., Kong, H. J., Boyd, J. H., Wang, Y., Russell, J. A., & Walley, K. R. (2016). Lipopolysaccharide is cleared from the circulation by hepatocytes via the low density lipoprotein receptor. PLoS One, 11(5), e0155030."}, {"Citation": "Tsimikas, S., Fazio, S., Ferdinand, K. C., Ginsberg, H. N., Koschinsky, M. L., Marcovina, S. M., Moriarty, P. M., Rader, D. J., Remaley, A. T., Reyes\u2010Soffer, G., Santos, R. D., Thanassoulis, G., Witztum, J. L., Danthi, S., Olive, M., & Liu, L. (2018). NHLBI working group recommendations to reduce lipoprotein(a)\u2010mediated risk of cardiovascular disease and aortic stenosis. Journal of the American College of Cardiology, 71(2), 177\u2013192."}, {"Citation": "Tuan, P. A., Kim, J. K., Lee, S., Chae, S. C., & Park, S. U. (2013). Molecular characterization of carotenoid cleavage dioxygenases and the effect of gibberellin, abscisic acid, and sodium chloride on the expression of genes involved in the carotenoid biosynthetic pathway and carotenoid accumulation in the callus of Scutellaria baicalensis Georgi. Journal of Agricultural and Food Chemistry, 61(23), 5565\u20135572."}, {"Citation": "Vahedian\u2010Azimi, A., Beni, F. H., Fras, Z., Banach, M., Mohammadi, S. M., Jamialahmadi, T., & Sahebkar, A. (2023). Effects of statins on the incidence and outcomes of acute kidney injury in critically ill patients: A systematic review and meta\u2010analysis. Archives of Medical Science, 19(4), 952\u2013964."}, {"Citation": "Vahedian\u2010Azimi, A., Mannarino, M. R., Shojaie, S., Rahimibashar, F., Galeh, H. E. G., Banach, M., Bianconi, V., Pirro, M., & Sahebkar, A. (2022). Effect of statins on prevalence and mortality of influenza virus infection: A systematic review and meta\u2010analysis. Archives of Medical Science, 18(6), 1\u201344."}, {"Citation": "Vahedian\u2010Azimi, A., Mohammadi, S. M., Banach, M., Beni, F. H., Guest, P. C., Al\u2010Rasadi, K., Jamialahmadi, T., & Sahebkar, A. (2021). Improved COVID\u201019 outcomes following statin therapy: An updated systematic review and meta\u2010analysis. BioMed Research International, 2021, 1\u201320."}, {"Citation": "Varbo, A., Benn, M., & Nordestgaard, B. G. (2014). Remnant cholesterol as a cause of ischemic heart disease: Evidence, definition, measurement, atherogenicity, high risk patients, and present and future treatment. Pharmacology & Therapeutics, 141(3), 358\u2013367."}, {"Citation": "Varbo, A., Benn, M., Tybj\u00e6rg\u2010Hansen, A., J\u00f8rgensen, A. B., Frikke\u2010Schmidt, R., & Nordestgaard, B. G. (2013). Remnant cholesterol as a causal risk factor for ischemic heart disease. Journal of the American College of Cardiology, 61(4), 427\u2013436."}, {"Citation": "Wang, J., Wang, Y. S., Huang, Y. P., Jiang, C. H., Gao, M., Zheng, X., Yin, Z. Q., & Zhang, J. (2021). Gypenoside LVI improves hepatic LDL uptake by decreasing PCSK9 and upregulating LDLR expression. Phytomedicine, 91, 153688."}, {"Citation": "Wang, M., Zhao, D., Xu, L., Guo, W., Nie, L., Lei, Y., Long, Y., Liu, M., Wang, Y., Zhang, X., Zhang, L., Li, H., Zhang, J., Yuan, D., & Yue, L. (2019). Role of PCSK9 in lipid metabolic disorders and ovarian dysfunction in polycystic ovary syndrome. Metabolism, 94, 47\u201358."}, {"Citation": "Wang, Y., Ye, J., Li, J., Chen, C., Huang, J., Liu, P., & Huang, H. (2016). Polydatin ameliorates lipid and glucose metabolism in type 2 diabetes mellitus by downregulating proprotein convertase subtilisin/kexin type 9 (PCSK9). Cardiovascular Diabetology, 15, 19."}, {"Citation": "Watts, G. F., Chan, D. C., Dent, R., Somaratne, R., Wasserman, S. M., Scott, R., Burrows, S., & Barrett, P. H. (2017). Factorial effects of evolocumab and atorvastatin on lipoprotein metabolism. Circulation, 135(4), 338\u2013351."}, {"Citation": "Xiao, H. B., Sun, Z. L., Zhang, H. B., & Zhang, D. S. (2012). Berberine inhibits dyslipidemia in C57BL/6 mice with lipopolysaccharide induced inflammation. Pharmacological Reports, 64(4), 889\u2013895."}, {"Citation": "Zhang, X., Li, H., Wang, W., Chen, T., & Xuan, L. (2020). Lipid\u2010lowering activities of Cucurbitacins isolated from Trichosanthes cucumeroides and their synthetic derivatives. Journal of Natural Products, 83(12), 3536\u20133544."}, {"Citation": "Zhao, Z., Tuakli\u2010Wosornu, Y., Lagace, T. A., Kinch, L., Grishin, N. V., Horton, J. D., Cohen, J. C., & Hobbs, H. H. (2006). Molecular characterization of loss\u2010of\u2010function mutations in PCSK9 and identification of a compound heterozygote. American Journal of Human Genetics, 79(3), 514\u2013523."}], "Title": "REFERENCES"}], "History": [{"Year": "2024", "Month": "4", "Day": "25"}, {"Year": "2023", "Month": "2", "Day": "3"}, {"Year": "2024", "Month": "5", "Day": "22"}, {"Year": "2024", "Month": "6", "Day": "20", "Hour": "12", "Minute": "42"}, {"Year": "2024", "Month": "6", "Day": "20", "Hour": "12", "Minute": "42"}, {"Year": "2024", "Month": "6", "Day": "20", "Hour": "7", "Minute": "13"}], "PublicationStatus": "aheadofprint", "ArticleIdList": ["38899632", "10.1002/ptr.8260"]}}]}